IS8496A - Samsetningar til meðhöndlunar á fjölgunarsjúkdómum - Google Patents
Samsetningar til meðhöndlunar á fjölgunarsjúkdómumInfo
- Publication number
- IS8496A IS8496A IS8496A IS8496A IS8496A IS 8496 A IS8496 A IS 8496A IS 8496 A IS8496 A IS 8496A IS 8496 A IS8496 A IS 8496A IS 8496 A IS8496 A IS 8496A
- Authority
- IS
- Iceland
- Prior art keywords
- propagating
- diseases
- compositions
- treatment
- propagating diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001902 propagating effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51955103P | 2003-11-12 | 2003-11-12 | |
| US10/855,130 US20050100508A1 (en) | 2003-11-12 | 2004-05-27 | Methods for identifying drug combinations for the treatment of proliferative diseases |
| PCT/US2004/037527 WO2005046607A2 (en) | 2003-11-12 | 2004-11-09 | Combinations for the treatment of proliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8496A true IS8496A (is) | 2006-06-02 |
Family
ID=34556562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8496A IS8496A (is) | 2003-11-12 | 2006-06-02 | Samsetningar til meðhöndlunar á fjölgunarsjúkdómum |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1689352A2 (is) |
| JP (1) | JP2007524657A (is) |
| KR (1) | KR20060118514A (is) |
| AR (1) | AR046841A1 (is) |
| AU (1) | AU2004289311A1 (is) |
| BR (1) | BRPI0416390A (is) |
| CA (1) | CA2545423A1 (is) |
| IL (1) | IL175611A0 (is) |
| IS (1) | IS8496A (is) |
| NO (1) | NO20062358L (is) |
| RU (1) | RU2006120491A (is) |
| TW (1) | TW200526777A (is) |
| WO (1) | WO2005046607A2 (is) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009225877B2 (en) * | 2008-03-18 | 2014-11-20 | Genentech, Inc. | Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2235420A1 (en) * | 1998-06-17 | 1999-12-17 | Paolo Renzi | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
-
2004
- 2004-11-05 TW TW093133826A patent/TW200526777A/zh unknown
- 2004-11-09 WO PCT/US2004/037527 patent/WO2005046607A2/en not_active Ceased
- 2004-11-09 BR BRPI0416390-7A patent/BRPI0416390A/pt not_active Application Discontinuation
- 2004-11-09 KR KR1020067010335A patent/KR20060118514A/ko not_active Withdrawn
- 2004-11-09 EP EP04810676A patent/EP1689352A2/en not_active Withdrawn
- 2004-11-09 RU RU2006120491/15A patent/RU2006120491A/ru not_active Application Discontinuation
- 2004-11-09 AU AU2004289311A patent/AU2004289311A1/en not_active Abandoned
- 2004-11-09 CA CA002545423A patent/CA2545423A1/en not_active Abandoned
- 2004-11-09 JP JP2006539813A patent/JP2007524657A/ja active Pending
- 2004-11-12 AR ARP040104188A patent/AR046841A1/es unknown
-
2006
- 2006-05-11 IL IL175611A patent/IL175611A0/en unknown
- 2006-05-23 NO NO20062358A patent/NO20062358L/no not_active Application Discontinuation
- 2006-06-02 IS IS8496A patent/IS8496A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2006120491A (ru) | 2007-12-20 |
| AU2004289311A1 (en) | 2005-05-26 |
| EP1689352A2 (en) | 2006-08-16 |
| BRPI0416390A (pt) | 2007-02-21 |
| AR046841A1 (es) | 2005-12-28 |
| NO20062358L (no) | 2006-07-12 |
| KR20060118514A (ko) | 2006-11-23 |
| CA2545423A1 (en) | 2005-05-26 |
| WO2005046607A3 (en) | 2012-12-20 |
| IL175611A0 (en) | 2008-04-13 |
| WO2005046607A2 (en) | 2005-05-26 |
| TW200526777A (en) | 2005-08-16 |
| JP2007524657A (ja) | 2007-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| IS8142A (is) | Læknislyf gagnleg til meðferðar á verkjum | |
| IS8516A (is) | Fosfónöt, monofosfónamidöt, bisfosfónamidöt til meðhöndlunar á veirusjúkdómum | |
| DK1701941T3 (da) | Forbindelser til behandling af sygdomme med celleproliferation | |
| IS8398A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| IS7099A (is) | Efnasambönd til að meðhöndla bólgutruflanir | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| DK1592384T3 (da) | Cop 1 til behandling af inflammatoriske tarmsygdomme | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| IS8246A (is) | Meðferð á taugahrörnunarástandi | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| IS7444A (is) | Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum | |
| IL175535A (en) | Compositions for treatment of neurodegenerative diseases | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| NO20054598D0 (no) | Beta-karboliner anvendbare for behandling av betennelsessykdommer | |
| EP1611120A4 (en) | NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| EP1965827A4 (en) | TREATMENT OF CONDITIONS RELATED TO DEMYELINATION | |
| DK1597171T3 (da) | Terapeutisk mikroskum | |
| IS8497A (is) | Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma |